Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × darolutamide × Clear all

NCT03568656 2025-08-08

Study to Evaluate CCS1477 in Advanced Tumours

Phase 1/2 Completed

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung